![](/img/cover-not-exists.png)
EDP-305, a non-bile acid farnesoid X receptor (FXR) agonist, showed statistically significant improvements in liver biochemistry and hepatic steatosis in the phase 2a argon-1 study
Ratziu, Vlad, Rinella, Mary, Tetri, Brent, Lawitz, Eric, Denham, Douglas, Kayali, Zeid, Sheikh, Aasim, Kowdley, Kris V., Desta, Taddese, Elkhashab, Magdy, DeGrauw, Jeffery, Ahmad, Alaa, Larson, Kajal,Volume:
73
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(20)30657-7
Date:
August, 2020
File:
PDF, 108 KB
2020